MedTrace Logo

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

NCT01519934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2017-12-18

Study results available
· View outcomes & findings →

Summary

Up to 120 subjects within the study site's practice who have already had an Ultherapy™ treatment to the face and neck will be enrolled to monitor treatment effectiveness. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained at each follow-up visit.

Conditions

  • Skin Laxity
  • Wrinkles

Sponsors & Collaborators

  • Ulthera, Inc

    lead INDUSTRY

Principal Investigators

  • Mitchel Goldman, MD · Dermatology Cosmetic Laser Associates

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-04-30
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01519934 on ClinicalTrials.gov